RxDoctor Payments Data

Andrew Kuntz, MD

Orthopaedic Surgery · Philadelphia, PANPI 1184784001

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Catalyst Orthoscience at 53.1% of the total. Reporting peaked in 2022 at $3,198 and has fallen 84.0% since, to $511 in 2025.

$6,353in general payments, 2019–2025

Across 31 payments — averaging $204.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Catalyst Orthoscience$3K
  • Orthofix Medical, Inc.$1K
  • Liberty Surgical Inc.$806
  • Stryker$380
  • Encore Medical, LP$214
  • Smith+Nephew$171
  • plus $312 from 3 others
$928,534in research payments, 2019–2025

Across 89 payments — averaging $10,433 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$619K
  • FX Shoulder Solutions, Inc$140K
  • Smith+Nephew$107K
  • Integra Lifesciences Corporation$63K

What the payments were for

  • Consulting fees$3,03748%
  • Travel & lodging$4227%
  • Food & beverage$2,08833%
  • Education$80613%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,353 in reported general payments places this provider in the 60th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$95,410
Medicare patients
353
Services billed
731

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →